Outlook Therapeutics
OTLK
$8.41
Share price
-2.32%
Change (1 day)
678.70%
Change (1 year)
Categories
Market capitalization of Outlook Therapeutics (OTLK)
Market cap: $0.18 Billion
As of April 2024 Outlook Therapeutics has a market cap of $0.18 Billion. This makes Outlook Therapeutics the world's 6975th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Outlook Therapeutics from 2016 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $0.18 B | 82.88% |
| 2023 | $0.10 B | -58.02% |
| 2022 | $0.24 B | -19.92% |
| 2021 | $0.30 B | 84.47% |
| 2020 | $0.16 B | 629.19% |
| 2019 | $22.67 M | -46.71% |
| 2018 | $42.54 M | 28.19% |
| 2017 | $33.18 M | -53.24% |
| 2016 | $70.97 M |
End of Day market cap according to different sources
On Apr 17th, 2024 the market cap of Outlook Therapeutics was reported to be:
$0.19 Billion
$0.19 Billion
$0.11 Billion
$0.18 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Organovo ONVO | $12.79 M | -93.18% | 🇺🇸 USA |
 Orchard Therapeutics
ORTX | $0.38 B | 102.69% | 🇬🇧 UK |
 Novavax NVAX | $0.55 B | 193.67% | 🇺🇸 USA |
 Novocure
NVCR | $1.28 B | 584.71% | Jersey |